Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2023
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung CancerSamuel Rosner, Joshua E Reuss, Marianna Zahurak, et al.
The New England Journal of Medicine|June 5, 2023
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung CancerHeather Wakelee, Moishe Liberman, Terufumi Kato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2018
SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung CancerNathan A Pennell, Joel W Neal, Jamie E Chaft, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 24, 2024
High-risk features associated with recurrence in stage I lung adenocarcinomaCameron N Fick, Elizabeth G Dunne, Stijn Vanstraelen, et al.
JTO Clinical and Research Reports|September 30, 2021
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLCAnnemarie F Shepherd, Anthony F Yu, Michelle Iocolano, et al.
Nature Communications|July 15, 2023
Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLCJoao V Alessi, Biagio Ricciuti, Xinan Wang, et al.
The Annals of Thoracic Surgery|February 5, 2024
The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung CancerElizabeth G Dunne, Cameron N Fick, James M Isbell, et al.
JCO Precision Oncology|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung CancerN Ari Wijetunga, Nikhil P Mankuzhy, Emily S Lebow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2018
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung CancerKathryn C Arbour, Laura Mezquita, Niamh Long, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2022
Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancerHarry B Lengel, Junting Zheng, Kay See Tan, et al.
Pageof 14